Reference
National Institute for Health and Care Excellence (NICE). NICE draft guidance recommends apalutamide for treating prostate cancer. Internet Document : 14 Sep 2021. Available from: URL: https://www.nice.org.uk/News/Article/nice-draft-guidance-recommends-apalutamide-for-treating-prostate-cancer
Rights and permissions
About this article
Cite this article
NICE's final draft recommends apalutamide for prostate cancer after price discount. PharmacoEcon Outcomes News 887, 33 (2021). https://doi.org/10.1007/s40274-021-08049-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-08049-0